Tawasil, Monera F.

HRN: 22-53-12  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
CEFTRIAXONE 1G (VIAL)
07/17/2023
07/24/2023
IV DRIP
640mg
Q24
PCAP C
Checking Final Appropriateness 
07/15/2024
CEFUROXIME 1.5GM (VIAL)
07/15/2024
07/22/2024
INTRAVENOUS
350 Mg IVTT
Every 8 Hours
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: